Russia's Putin is spending $26 billion to live forever - Startup Fortune

Your subscription could not be saved. Please try again.

Your subscription has been successful.

AI Briefing

5 most important AI updates after 8pm every day, curated for you.

Subscribe free

Search

SF

Jun 20, 2026 · 11:10 PM

US|<br>INTERNATIONAL|<br>ASIA|<br>SF Featured

Subscribe✉

Most Read

Hyundai takes full control of Boston…<br>Big Tech is borrowing like never…<br>Ant Group is rebuilding Alipay around…<br>An Atlantic investigation just blew open…<br>Hyundai takes full control of Boston…<br>Big Tech is borrowing like never…<br>Ant Group is rebuilding Alipay around…<br>An Atlantic investigation just blew open…

Home<br>News

Russia's Putin is spending $26 billion to live forever

Russia's $26 billion state longevity program, run by Putin's daughter and a close ally, is chasing organ bioprinting and pig-grown transplants by 2030. The science hasn't kept up.

Dave Barr

Jun 21, 2026 · 4:26 AM ·<br>4 min read<br>77 views

this.classList.remove('sf-copied'),1500)" aria-label="Copy link">

Have you heard about Vladimir Putin's latest project? If you thought running a country was enough, think again. He's now in the business of trying to live forever.

Russia's state-backed longevity program, formally called New Health Preservation Technologies, carries a price tag of roughly $26 billion. For a country that has lost nearly half a million soldiers in Ukraine, it's a striking place to put money. But this program isn't really for Russia. It's for one person.

Last September, at a military parade in Beijing, Putin leaned toward Xi Jinping and told him, with an open microphone between them, that human organs could be "constantly transplanted" to the point where people "get younger, perhaps even immortal." Most of the world treated it as eccentric small talk between aging autocrats. It wasn't small talk at all. It was a policy announcement.

The program was unveiled in 2024 and runs through the end of the decade. To put the cost in context, it works out to about $196 per Russian citizen. A government billing its own people for one man's fear of death is a particular kind of governance.

The people running it

This isn't a public health initiative staffed by career civil servants. Two figures sit at its center, and both are connected to Putin personally.

The first is his 41-year-old elder daughter, a pediatric endocrinologist who oversees the state's genetic research programs. The second is a 79-year-old physicist who heads the Soviet-era Kurchatov Institute, and whose brother is widely regarded as Putin's personal banker. This is run by family and inner circle. That distinction matters.

The physicist is the ideological engine behind the project. He has argued for years that science will eventually allow continuous repair and replacement of worn-out human body parts. He has also tied the program to Kremlin geopolitics, warning that the West is engineering "servant humans" through manipulated reproduction. The longevity program and the worldview wrapped around it are not separate things.

What the scientists are actually doing

The research breaks into a few distinct tracks.

Bioprinting, which means 3D printing living tissue layer by layer, is one. Scientists claim to have printed human cartilage tissue and a mouse thyroid gland, with full human organ replacement targeted by 2030. Xenotransplantation is the other main thrust, growing human-compatible organs inside genetically modified mini-pigs. Researchers are also developing what they describe as the world's first drug to slow cellular aging. And there's cryotherapy, exposure to ultralow temperatures to reset and preserve bodily tissues.

Putin, who turns 74 next month, has spent decades projecting physical vigor. Hunting shirtless. Playing hockey. Riding motorcycles. He told an AI conference not long ago that reaching 150 is "probably possible." The program is, in part, the infrastructure behind that belief.

Here's the problem

Russia's program has produced virtually no publications in peer-reviewed international journals. Researchers warn that officials may be presenting overly optimistic results to secure funding, and that science cannot advance in isolation. Western sanctions have severed Russian labs from much of the global scientific community. When your own researchers warn that people might be telling the boss what he wants to hear, that's a significant flag.

Longevity research funded by Silicon Valley billionaires at least submits to peer review. Russia's version submits to Putin. The gap between ambition and output isn't just a technical problem. It's a structural one. Any program whose primary mandate is keeping one man alive, and whose leadership is selected for personal loyalty rather than scientific standing, is going to struggle to generate results that actually move the needle.

That's the real story here, and it's not really about mini-pigs.

A 73-year-old authoritarian who believes his state cannot...